Skip to main content

Table 5 Clinical treatments and outcomes in nalidixic acid-susceptible Salmonella (NASS) and nalidixic acid-resistant Salmonella (NARS)-infected patients treated with fluoroquinolones onlya

From: Genetic Diversity of Salmonella enteric serovar Typhi and Paratyphi in Shenzhen, China from 2002 through 2007

Antimicrobial agents

 

NASS-infected patients (n = 6)

NARS-infected patients (n = 17)

 

Dosage

Number

Duration (d)

Number

Duration (d)

Ciprofloxacin

0.4 g IV q12h

5

7~13

8

7~21

 

0.2 g IV q12h

1

5

2

10~15

Levofloxacin

0.3 g IV q12h

-

-

1

7

 

0.2 g IV q12h

-

-

2

7~8

Gatifloxacin

0.2 g IV q12h

-

-

3

10~14

 

0.4 g IV q24h

-

-

1

13

  1. aAll of these 23 patients treated with fluoroquinolones only were cured.
Back to article page

BMC Microbiology

ISSN: 1471-2180

Contact us